Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration

Authors

  • Amrendar Kumar Assistant Professor, Department of Opthalmology, ESIC Medical College and Hospital, Bihta, Bihar, India
  • Anita Ambastha Additional Professor, Department of RIO, IGIMS, Patna, Bihar, India
  • Vidya Bhushan Kumar Assistant Professor, Department of Opthalmology, ESIC Medical College and Hospital, Bihta, Bihar, India

DOI:

https://doi.org/10.32553/ijmbs.v9i1.3030

Keywords:

nAMD

Abstract

Background: nAMD causes vision loss in older adults. Anti-VEGF therapy improves outcomes, but long-term real-world data are limited.

Objective: To assess 11-month outcomes of anti-VEGF therapy in nAMD patients.

Methods: 110 patients at ESIC Medical College received intravitreal anti-VEGF on a PRN regimen. BCVA and CMT were tracked over 11 months.

Results: Over 11 months, BCVA improved from 0.8 to 0.5 logMAR and CMT reduced from 420 µm to 300 µm. Vision improved in 65% of patients, with no major adverse events reported.

Conclusion: Anti-VEGF therapy is effective and safe for managing nAMD with a manageable injection burden.

Keywords: nAMD, anti-VEGF, BCVA, CMT

Downloads

Published

2025-02-27

How to Cite

Kumar, A. ., Ambastha, A. ., & Kumar, V. B. . (2025). Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration. International Journal of Medical and Biomedical Studies, 9(1), 199-204. https://doi.org/10.32553/ijmbs.v9i1.3030

Issue

Vol. 9 No. 1 (2025)

Section

Articles

License

Copyright (c) 2025 International Journal of Medical and Biomedical Studies

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.